O

Otsuka Pharmaceutical

Global pharma maker of Abilify

Director – Early Clinical Development - CNS

Biology & BiotechConfirmed live in the last 24 hours
Full-time

About the Job

Requirements

  • A medical degree, a medical degree and PhD, or a PhD with subspecialty training in clinical psychology or neuropsychology is required.
  • At least 5 years of translational medicine and/or early clinical development experience is required, with a track record of advancing biologics and/or small molecules through IND and first-in-human/proof-of-concept stages.
  • Expert understanding of industry best practices and adjacent functional areas is required.
  • Ability to coordinate and guide cross-functional teams in a matrixed, global setting is required.
  • Ability to think strategically and make informed decisions amid uncertainty is required.
  • Ability to synthesize complex data and influence executive stakeholders is required.
  • Outstanding communication skills are required.

Responsibilities

  • Lead activities related to Early Clinical Development essential to the growth of the discovery and early-phase pipeline.
  • Own end-to-end early clinical development strategy and execution for the early-phase portfolio, especially CNS programs in psychiatry, neurodegenerative disease, and neuroinflammation.
  • Shape program strategy from indication selection through early clinical development, from pre-IND through first-in-human and clinical proof of concept, and make go/no-go decisions using clinical and/or biomarker-driven endpoints.
  • Ensure seamless integration across discovery, nonclinical, clinical pharmacology, regulatory, and commercial functions.
  • Collaborate with Early Development Organization senior leaders to identify, introduce, and implement translational tools or studies for early-phase programs and establish strategic plans and objectives.
  • Serve as a scientific and clinical expert in CNS translational medicine and early clinical development, contributing to strategic program decisions and serving as ECD lead on development teams for multiple assets.
  • Drive Research-to-Development strategies and stage-gate decisions, including indication prioritization and go/no-go decisions based on mechanistic rationale, benefit-risk, clinical unmet need, and clinical and/or biomarker-driven endpoints.
  • Prepare and present decision-quality data packages for internal governance reviews to support stage-gate decisions.
  • Interact with internal and external groups to evaluate new compounds, molecular and biological targets, and formulation technologies.
  • Partner with internal and external research organizations to facilitate development of early-phase and discovery-phase compounds.
  • Engage with external experts and key opinion leaders to inform translational and proof-of-concept strategy and maintain scientific leadership.
  • Represent ECD in cross-functional and internal/external collaborations, including business development activities related to early-phase target and asset identification.
  • Support regulatory interactions, including pre-IND and IND submissions, and ensure translational strategies align with regulatory requirements.
  • Lead scientific and clinical development efforts for assigned programs from target identification through IND and proof of concept.
  • Provide medical leadership for early-phase clinical protocols, informed consent forms, and investigator brochures; monitor safety and contribute to DSMB or safety review activities as needed.
  • Support or lead public-private partnerships in pre-competitive settings to advance internal clinical development capabilities.
  • Interact with other disciplines within the Early Development Organization to promote, initiate, and elevate cross-functional early development activities.
  • Collaborate with biomarker and digital innovation teams to develop and implement biomarker-driven approaches for CNS programs.
  • Support the development of team members to build translational and early clinical development expertise.

Desired Qualifications

  • An MD with specialty training in psychiatry and/or neurology is preferred.
  • Deep expertise in CNS, particularly psychiatry, neurodegenerative disease, and/or neuroinflammation, is preferred.
  • Experience implementing clinical study plans to drive decision-making is preferred.
  • Experience with external collaborations is preferred.

About the Company

Otsuka Pharmaceutical

Global pharma maker of Abilify

Otsuka Pharmaceutical develops and markets medicines and health products worldwide, including prescription drugs and nutraceutical beverages. Its product lineup ranges from pharmaceutical treatments such as Abilify (an antipsychotic) to consumer health drinks like Pocari Sweat, which helps replenish electrolytes. Abilify works as a psychiatric medication used to treat conditions such as schizophrenia and bipolar disorder, while Pocari Sweat is an ion-replacement beverage designed to restore minerals and fluids after activity or heat. The company differentiates itself through a long history dating back to its founding in 1921, a broad, globally scaled portfolio spanning drugs and health beverages, and a focus on health improvements across populations. Its stated goal is to create new products for better health worldwide.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Tokyo, Japan
Founded
1921

Recently Posted Jobs

Explore more opportunities at Otsuka Pharmaceutical

See more jobs